AIRQ® asthma refers to the Asthma Impairment and Risk Questionnaire, a 10-question, yes/no assessment tool used by healthcare providers and patients (12+) to gauge asthma control and predict future asthma attacks

By evaluating symptoms, medication use, and healthcare resource utilization over the past two weeks and past 12 months, the AIRQ generates a score indicating whether asthma is well-controlled, not well-controlled, or very poorly controlled.


The AIRQ has been validated in multiple languages (plain language summary can be found in George et al. 2025). 

Purpose of the AIRQ

  • Identify Uncontrolled Asthma: The AIRQ helps pinpoint patients whose asthma may not be adequately controlled, prompting further discussion with a healthcare provider.
  • Discuss Asthma Control: It serves as a tool to initiate conversations between patients and their healthcare providers about current asthma control levels.
  • Assess Exacerbation Risk: A higher score can indicate a greater risk of asthma attacks or exacerbations.

How the AIRQ Works

  • 10 Yes/No Questions: The questionnaire asks 10 questions covering factors like symptoms, activity limitations, sleep disturbance, and the use of rescue medication. 
  • Impairment and Risk Items: Seven items focus on past two weeks of impairment (symptoms and activity), while three focus on the past 12 months of risk (medication use, symptoms, and exacerbations). 
  • Scoring: Responses are tallied into a score from 0 to 10.
    • 0–1 Yes answers: Well-controlled asthma. 
    • 2–4 Yes answers: Not well-controlled asthma.  
    • 5–10 Yes answers: Very poorly controlled asthma

Important Considerations

  • AIRQ is not a Diagnostic Tool: it does not diagnose asthma but assesses its control.
  • Discuss with Your Provider: Patients should always discuss their AIRQ answers and scores with a healthcare professional to determine if treatment adjustments are needed.
  • AIRQ questionnaire is designed for individuals aged 12 and above. The Peds-AIRQ is a recently validated assessment tool for children aged 5 to 11 years (Murphy et al. 2025)

Download Resources

Click a link below to download a resource:

Click a link below to download a resource:

AIRQ® online demo click: https://www.asthmaresourcecenter.com/home/airq.html

Peds-AIRQ® online demo click here: https://www.asthmaresourcecenter.com/home/peds-airq.html

Useful References

  1. George, Maureen et al. “What is the Asthma Impairment and Risk Questionnaire and how can it help patients with asthma? A plain language summary of publications.” Therapeutic advances in respiratory disease vol. 19 (2025): 17534666251384465. doi:10.1177/17534666251384465
  2. Murphy, Kevin R et al. “Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure.” The journal of allergy and clinical immunology. In practice vol. 8,7 (2020): 2263-2274.e5. doi:10.1016/j.jaip.2020.02.042
  3. Chipps, Bradley E et al. “Advancing assessment of asthma control with a composite tool: The Asthma Impairment and Risk Questionnaire.” Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology vol. 133,1 (2024): 49-56. doi:10.1016/j.anai.2024.03.011
  4. Kanniess, F., Defosse, K., Lommatzsch, M., Schultz, T., Timmermann, H., Schmidt, O., Heindl, S., Baumann, H. J., Buhl, R., Taube, C., Höing, F., & Korn, S. (2024). Validation of the German version of the Asthma Impairment and Risk Questionnaire (AIRQ). Validierung der deutschen Version des Asthma Impairment and Risk Questionnaires (AIRQ). Pneumologie (Stuttgart, Germany), 78(11), 912–921. https://doi.org/10.1055/a-2346-9840
  5. Beuther, David A et al. “The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma Exacerbations.” The journal of allergy and clinical immunology. In practice vol. 10,12 (2022): 3204-3212.e2. doi:10.1016/j.jaip.2022.08.017
  6. Murphy, Kevin R et al. “Pediatric Asthma Impairment and Risk Questionnaire: A Control Assessment for Children Aged 5 to 11 Years.” The journal of allergy and clinical immunology. In practice vol. 13,10 (2025): 2659-2671. doi:10.1016/j.jaip.2025.06.039
  7. Global Initiative for asthma 2026 strategy https://ginasthma.org/2026-gina-slide-sets/

AIRQ questionnaire is designed for individuals aged 12 and above. The Peds-AIRQ is a recently validated assessment tool for children aged 5 to 11 years (Murphy et al. 2025) and it was included in GINA 2026 Strategy (7)